Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma

(2019) Junyu Long et al.   EBioMedicine

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

(2019) Gaurav Singal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Neuropilin-1 is associated with the prognosis of cervical cancer in Henan Chinese population

(2019) Li Yang et al.   OncoTargets and Therapy

Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness

(2019) Aaron M. Goodman et al.   Cancer Immunology Research

Development and validation of an immune-related gene pairs signature in colorectal cancer

(2019) Jianping Wu et al.   OncoImmunology

Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

(2019) Fouad Mehraban et al.   Journal of Translational Medicine

A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite

(2019) Laura-Oana Albulescu et al.   Frontiers in Pharmacology

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

(2018) Matthew D. Hellmann et al.   CANCER CELL

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report

(2018) Yuki Owada-Ozaki et al.   Journal of Thoracic Oncology

A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production

(2018) Adri�n Ram�rez De Arellano et al.   ONCOLOGY REPORTS

Precision Lasso: Accounting for Correlations and Linear Dependencies in High-Dimensional Genomic Data

(2018) Haohan Wang et al.   BIOINFORMATICS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

(2018) Jason Roszik et al.   Frontiers in Immunology

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

(2018) Jingjing Zhu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Maftools: efficient and comprehensive analysis of somatic variants in cancer

(2018) Anand Mayakonda et al.   GENOME RESEARCH

Construction of immune-related risk signature for renal papillary cell carcinoma

(2018) Zhongyu Wang et al.   Cancer Medicine

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

(2018) Sipeng Shen et al.   EBioMedicine

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial

(2017) Jean-Sebastien Frenel et al.   JOURNAL OF CLINICAL ONCOLOGY

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

(2017) Jacob Schachter et al.   LANCET

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

(2017) Aaron M. Goodman et al.   MOLECULAR CANCER THERAPEUTICS

Integrative clinical genomics of metastatic cancer

(2017) Dan R. Robinson et al.   NATURE

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators

(2017) Yong Qin et al.   Frontiers in Immunology

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

(2016) Willy Hugo et al.   CELL

Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?

(2016) Young Kwang Chae et al.   Clinical Lung Cancer

B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer

(2016) Alexandre Tang et al.   INTERNATIONAL JOURNAL OF CANCER

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

(2016) Roy S Herbst et al.   LANCET

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

(2016) Geoffrey T Gibney et al.   LANCET ONCOLOGY

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

(2016) D. B. Johnson et al.   Cancer Immunology Research

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

(2016) Giuseppe V. Masucci et al.   Journal for ImmunoTherapy of Cancer

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Regularization Paths for Generalized Linear Models via Coordinate Descent

(2015) Jerome Friedman et al.   Journal of Statistical Software

New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy

(2014) K. S. Tewari et al.   CLINICAL CANCER RESEARCH

ImmPort: disseminating data to the public for the future of immunology

(2014) Sanchita Bhattacharya et al.   IMMUNOLOGIC RESEARCH

Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality

(2014) Marine Lorent et al.   STATISTICS IN MEDICINE

High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer

(2014) A. M. Heeren et al.   Cancer Immunology Research

Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma

(2013) P.J. de Vos van Steenwijk et al.   INTERNATIONAL JOURNAL OF CANCER

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma

(2013) Wiebke Hansen   OncoImmunology

Model based period analysis of absolute and relative survival with R: Data preparation, model fitting and derivation of survival estimates

(2012) Bernd Holleczek et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Neuropilin 1 deficiency on CD4+Foxp3+regulatory T cells impairs mouse melanoma growth

(2012) Wiebke Hansen et al.   JOURNAL OF EXPERIMENTAL MEDICINE

survcomp: an R/Bioconductor package for performance assessment and comparison of survival models

(2011) Markus S. Schröder et al.   BIOINFORMATICS

TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells

(2011) M. Iyori et al.   JOURNAL OF IMMUNOLOGY

Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway

(2011) C L Au Yeung et al.   ONCOGENE

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Leptin Receptor-Related Immune Response in Colorectal Tumors: The Role of Colonocytes and Interleukin-8

(2008) M. Abolhassani et al.   CANCER RESEARCH